Bermekimab
Bermekimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Bermekimab is under investigation in clinical trial NCT01384630 (Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis).
Trade Name | Bermekimab |
Generic | Bermekimab |
Bermekimab Other Names | Bermekimab, RA-18C3 |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Bermekimab